CIK: 0001910264
Total reported value
$915.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | Stock-Other | 39.29% | +7.77% | — | |
| 2 | ZBIO | Zenas Biopharma INC | Stock-Other | 16.66% | -15.14% | — | |
| 3 | SPRY | Ars Pharmaceuticals INC | Stock-Other | 11.67% | -3.10% | — | |
| 4 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 9.88% | -4.55% | — | |
| 5 | DSGN | Design Therapeutics INC | Stock-Other | 7.04% | -1.08% | — | |
| 6 | MLYS | Mineralys Therapeutics INC | Stock-Other | 4.90% | -3.40% | — | |
| 7 | ALMS | Alumis INC | Stock-Other | 4.20% | +2.01% | — | |
| 8 | NKTX | Nkarta INC | Stock-Other | 3.02% | -0.10% | — | |
| 9 | ORKA | Oruka Therapeutics INC | Stock-Other | 1.84% | +0.46% | — | |
| 10 | ✓ | Engene Holdings INC | Stock-Other | 0.99% | -0.40% | +49.55% | |
| 11 | KALAEUR | Kala Bio INC | Stock-Other | 0.51% | — | — |